BJ Turner

Investor

2 past transactions

RealSeq Biosciences

Seed Round in 2023
RealSeq Biosciences specializes in innovative, proprietary technologies for constructing unbiased small RNA and miRNA libraries for next-generation sequencing (NGS). Their core product, RNA fragmentomics technology, enables real-time disease detection, enhancing diagnosis and treatment in cancer and infectious diseases. This technology facilitates biomarker discovery, liquid biopsy, and single-cell analysis, ultimately improving patient outcomes through innovative RNA-based services.

ARwall

Series A in 2019
ARwall, Inc. is a developer of augmented reality tools aimed at enhancing digital filmmaking. Founded in 2017 and headquartered in Studio City, California, the company offers innovative solutions such as ARwall FX, an augmented reality display designed for visual effects in film and television, and AR3D, which allows users to interact with virtual and augmented reality experiences by creating an illusion of a virtual window. ARwall's technology eliminates the need for headsets or goggles, integrating spatial imaging to streamline the production workflow by removing traditional green screens. The company serves a range of professionals in the film industry, including filmmakers, cinematographers, production designers, and CG technical artists, and also operates a phase 2 production studio in Los Angeles. Through its offerings, ARwall aims to provide comprehensive consulting and turnkey solutions that encompass creative, hardware, software, and immersive experiences for creators of all levels.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.